72 studies found for:    cholangiocarcinoma | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Device: TheraSphere® Yttrium-90 (Y-90) Microspheres
22 Recruiting Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Liver Neoplasms
Interventions: Drug: Floxuridine;   Drug: Dexamethasone;   Drug: Gemcitabine;   Drug: Oxaliplatin
23 Recruiting Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
Conditions: Solid Tumors;   Thyroid Cancer;   Soft-tissue Sarcoma;   Cholangiocarcinoma
Interventions: Drug: Pazopanib;   Drug: GSK1120212
24 Recruiting A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Condition: Cholangiocarcinoma
Interventions: Drug: Amphinex and Gemcitabine;   Drug: Gemcitabine and Cisplatin
25 Recruiting A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Condition: Metastatic Biliary Tract Carcinoma
Intervention: Drug: Regorafenib
26 Recruiting A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Condition: Cholangiocarcinoma
Intervention: Drug: Gemcitabine
27 Recruiting IRS(Irradiation Stent) vs. CS(Conventional Stent) Insertion in Inoperable Malignant Biliary Obstruction
Condition: Cholangiocarcinoma
Interventions: Procedure: Stenting;   Device: self-expandable metallic biliary stent loaded with 125 iodine seeds;   Device: conventional biliary self-expandable stent;   Procedure: brachytherapy
28 Recruiting Endobiliary RFA for Unresectable Malignant Biliary Strictures
Conditions: Cholangiocarcinoma;   Ampullary Carcinoma
Intervention: Procedure: Radiofrequency ablation (RFA)
29 Recruiting Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.
Condition: Cholangiocellular Carcinoma
Intervention: Drug: Cisplatin and Gemcitabine
30 Recruiting Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
Conditions: Carcinoma, Hepatocellular;   Intrahepatic Cholangiocarcinoma
Intervention: Radiation: Stereotactic radiation
31 Recruiting Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).
Condition: Intrahepatic Cholangiocellular Carcinoma
Interventions: Procedure: DEB TACE;   Procedure: SIRT
32 Recruiting Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin
Condition: Unresectable Intrahepatic Cholangiocarcinoma
Interventions: Device: LC Bead with Gem-Cis;   Drug: Gemcitabine and Cisplatin
33 Recruiting Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
Conditions: Liver Cancer;   Metastatic Cancer
Interventions: Drug: capecitabine;   Radiation: yttrium Y 90 glass microspheres
34 Recruiting Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
Conditions: Metastatic Liver Cancer;   Cholangiocarcinoma;   Neoplasm Metastasis
Intervention: Procedure: Irreversible electroporation (IRE)
35 Recruiting The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells
Condition: Cholangiocarcinoma
Intervention: Drug: cytokine induced killer cells
36 Recruiting Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Conditions: Hilar Cholangiocarcinoma;   Primary Sclerosing Cholangitis
Interventions: Procedure: Liver transplantation;   Radiation: 45 Gy external radiations;   Radiation: Endoluminal bile duct Brachytherapy;   Drug: Capecitabine;   Procedure: Pre liver transplantation laparoscopic hand assisted staging
37 Recruiting CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid
38 Recruiting Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
Condition: Hepatic Complications
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: sirolimus;   Procedure: quality-of-life assessment
39 Recruiting Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy
Condition: Cholangiocellular Carcinoma
Intervention: Drug: Selective intra-arterial floxuridine and systemic gemcitabine and cisplatin
40 Recruiting Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
Conditions: Pancreatic Cancer;   Cholangiocarcinoma
Intervention: Drug: Sildenafil

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years